title: Renal, endothelial function, warfarin management, and the CHADS2, CHA2DS2VASc and HAS-BLED scores inpredicting MACE in AF.
authors.affiliation: Dr. A. D. Blann, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, B18 7QH, United Kingdom, Tel.: +44 0 121 507 5076, Fax: +44 0 121 507 5076, E-mail: a.blann@bham.ac.uk.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Blann
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D000368:Aged; D000802:Angiotensin Amide; D000925:Anticoagulants / Q000737:chemistry; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications*; D002318:Cardiovascular Diseases / Q000097:blood / Q000150:complications*; D004730:Endothelium, Vascular / Q000473:pathology*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007249:Inflammation; D007668:Kidney / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012720:Severity of Illness Index; D012907:Smoking; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use*; D014841:von Willebrand Factor / Q000378:metabolism
chemical_list: D000925:Anticoagulants; D014841:von Willebrand Factor; D000802:Angiotensin Amide; D014859:Warfarin